Muthusamy, Nagendran
Williams, Taufika I.
O’Toole, Ryan
Brudvig, Jon J.
Adler, Kenneth B.
Weimer, Jill M.
Muddiman, David C.
Ghashghaei, H. Troy http://orcid.org/0000-0003-4306-5712
Funding for this research was provided by:
national institute of neurological disorders and stroke (R01NS098370)
Article History
Received: 22 July 2021
Accepted: 13 January 2022
First Online: 24 January 2022
Declarations
:
: KA holds 130,000 founders’ shares of a start-up biotech company, Biomarck, and serves as a scientific consultant without monetary compensation. KA receives over $100,000 yearly in research grants from the National Institutes of Health (NIH). The remaining authors have declared no competing interests.